Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study-Reference-Cited by-同舟云学术

Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study

Published:2017-06 Issue:6 Volume:17 Page:615-625
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Sáez-Llorens Xavier,Tricou Vianney,Yu Delia,Rivera Luis,Tuboi Suely,Garbes Pedro,Borkowski Astrid,Wallace Derek

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference28 articles.

1. The global distribution and burden of dengue;Bhatt;Nature,2013

2. Dengue;Simmons;N Engl J Med,2012

3. Dengue prevention and 35 years of vector control in Singapore;Ooi;Emerg Infect Dis,2006

4. National dengue surveillance in Cambodia 1980–2008: epidemiological and virological trends and the impact of vector control;Huy;Bull World Health Organ,2010

5. Dengue guidelines for diagnosis, treatment, prevention and control,2009

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity, Safety and Efficacy of the Dengue Vaccine TAK-003: A Meta-Analysis;Vaccines;2024-07-13

2. Regional Variation of the CD4 and CD8 T Cell Epitopes Conserved in Circulating Dengue Viruses and Shared with Potential Vaccine Candidates;Viruses;2024-05-05

3. Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination;The Journal of Infectious Diseases;2024-04-29

4. Systemic and Ocular Manifestations of Arboviral Infections: A Review;Ocular Immunology and Inflammation;2024-03-05

5. Integrated control strategies for dengue, Zika, and Chikungunya virus infections;Frontiers in Immunology;2023-12-18